Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality from Colorectal Cancer (CONFIRM): Rationale for Study Design

American Journal of Gastroenterology

Volumn 112, Issue 11, 2017, Pages 1736-1746

  Dominitz, Jason A ^a   Robertson, Douglas J ^b,n   Ahnen, Dennis J ^c   Allison, James E ^d   Antonelli, Margaret ^e   Boardman, Kathy D ^f   Ciarleglio, Maria ^g   Del Curto, Barbara J ^f   Huang, Grant D ^h   Imperiale, Thomas F ⁱ   Larson, Meaghan F ^j   Lieberman, David ^k   O'Connor, Theresa ^e   O'Leary, Timothy J ^c,o   Peduzzi, Peter ^g   Provenzale, Dawn ^l   Shaukat, Aasma ^m   Sultan, Shahnaz ^m   Voorhees, Amy ^b   Wallace, Robert ^e   Guarino, Peter D ^e,p   more..

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^f University of New Mexico   (United States)

^g YALE UNIVERSITY   (United States)

^h Office of Research and Development   (United States)

ⁱ INDIANA UNIVERSITY   (United States)

^j VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^k PORTLAND VA MEDICAL CENTER   (United States)

^l DUKE UNIVERSITY MEDICAL CENTER   (United States)

^m UNIVERSITY OF MINNESOTA   (United States)

ⁿ DARTMOUTH MEDICAL SCHOOL   (United States)

^o UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^p USA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL OUTCOME; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; MALE; MULTICENTER STUDY; OCCULT BLOOD TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; CARCINOMA; CHEMISTRY; COLORECTAL TUMOR; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; FECES; GOVERNMENT; IMMUNOCHEMISTRY; MIDDLE AGED; MORTALITY; OCCULT BLOOD; PROCEDURES; UNITED STATES;

HEMOGLOBIN;

AGED; CARCINOMA; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; OCCULT BLOOD; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 85032881635     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2017.286     Document Type: Article

References (34)

1. Siegel RL, Miller KD, Fedewa SA et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017; 67: 177-93.
2. Welch HG, Robertson DJ. Colorectal cancer on the decline-why screening can't explain it all. N Engl J Med 2016; 374: 1605-7.
3. Edwards BK, Ward E, Kohler BA et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116: 544-73.
4. Zauber AG. Th e impact of screening on colorectal cancer mortality and incidence: has it really made a diff erence? Dig Dis Sci 2015; 60: 681-91.
5. Rex DK, Boland CR, Dominitz JA et al. Colorectal cancer screening: recommendations for physicians and patients from the U. S. multi-society task force on colorectal cancer. Am J Gastroenterol 2017; 112: 1016-30.
6. U. S. Preventive Services Task Force. Bibbins-Domingo K, Grossman DC et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 2016; 315: 2564-75.
7. El-Serag HB, Petersen L, Hampel H et al. Th e use of screening colonoscopy for patients cared for by the Department of Veterans Aff airs. Arch Intern Med 2006; 166: 2202-8.
8. Centers for Disease C, Prevention. Vital signs: colorectal cancer screening test use-United States, 2012. MMWR Morb Mortal Wkly Rep 2013; 62: 881-8.
9. Hewitson P, Ward AM, Heneghan C et al. Primary care endorsement letter and a patient leafl et to improve participation in colorectal cancer screening: results of a factorial randomised trial. Br J Cancer 2011; 105: 475-80.
10. Zajac IT, Whibley AH, Cole SR et al. Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: A longitudinal analysis. J Med Screen 2010; 17: 19-24.
11. Cole S, Young G, Byrne D et al. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen 2002; 9: 147-52.
12. Condon DL, Beck D, Kenworthy-Heinige T et al. A cross-cutting approach to enhancing clinical trial site success: Th e Department of Veterans Aff airs' Network of Dedicated Enrollment Sites (NODES) model. Contemp Clin Trials Commun 2017; 6: 78-84.
13. Libby G, Bray J, Champion J et al. Pre-notifi cation increases uptake of colorectal cancer screening in all demographic groups: A randomized controlled trial. J Med Screen 2011; 18: 24-9.
14. U. S. Department of Veterans Aff airs. U. S. Department of Veterans Aff airs. VHA Directive 1015: Colorectal Cancer Screening. 2014 (cited on 27 March 2017); Available at https://www. va. gov/vhapublications/publications. cfm?pub=1.
15. Lieberman DA, Rex DK, Winawer SJ et al. Guidelines for colonoscopy surveillance aft er screening and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143: 844-57.
16. Sohn MW, Arnold N, Maynard C et al. Accuracy and completeness of mortality data in the Department of Veterans Aff airs. Popul Health Metr 2006; 4: 2.
17. Park LS, Tate JP, Rodriguez-Barradas MC et al. Cancer incidence in HIV-infected vs. uninfected veterans: comparison of cancer registry and ICD-9 code diagnoses. J AIDS Clin Res 2014; 5: 1000318.
18. National Cancer Institute. Surveillance, Epidemiology, and End Result Program: Quality Improvement Process. (cited on 27 March 2017); Available at https://seer. cancer. gov/qi/process. html.
19. Kahi CJ, Hewett DG, Norton DL et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011; 9: 42-6.
20. Barclay RL, Vicari JJ, Doughty AS et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006; 355: 2533-41.
21. Corley DA, Jensen CD, Marks AR et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014; 370: 1298-306.
22. Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colono scopy and the risk of interval cancer. N Engl J Med 2010; 362: 1795-803.
23. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71.
24. Muller AD, Sonnenberg A. Prevention of colorectal cancer by fl exible endoscopy and polypectomy. A case-control study of 32, 702 veterans. Ann Intern Med 1995; 123: 904-10.
25. Baxter NN, Goldwasser MA, Paszat LF et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009; 150: 1-8.
26. Kahi CJ, Imperiale TF, Juliar BE et al. effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009; 7: 770-5. quiz 711.
27. Lee JK, Liles EG, Bent S et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 2014; 160: 171.
28. Hoff G, Grotmol T, Skovlund E et al. Risk of colorectal cancer seven years aft er fl exible sigmoidoscopy screening: randomised controlled trial. BMJ 2009; 338: b1846.
29. Quintero E, Castells A, Bujanda L et al. Colonoscopy vs. fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012; 366: 697-706.
30. Kaminski MF, Bretthauer M, Zauber AG et al. Th e NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 2012; 44: 695-702.
31. Screesco trial at http://www. clinicaltrials. gov/ct2/show/NCT02078804. (Accessed on 27 March 2017). (Cited on 16 November 2014); Available at http://www. clinicaltrials. gov/ct2/show/NCT02078804.
32. Bretthauer M, Kaminski MF, Loberg M et al. Population-based colonoscopy screening for colorectal cancer: A randomized clinical trial. JAMA Intern Med 2016; 176: 894-902.
33. Binefa G, Garcia M, Mila N et al. Colorectal Cancer Screening Programme in Spain: results of key performance indicators aft er fi ve rounds (2000-2012). Sci Rep 2016; 6: 19532.
34. Fedewa SA, Ma J, Sauer AG et al. How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018? Cancer 2015; 121: 4258-65.